← Eichor
Condition: Treatment Resistant Obsessive Compulsive Disorder Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Treatment Resistant Obsessive Compulsive Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS
NA · 8 location(s) · University Hospital, Grenoble · NCT02844049
TMS for Exposure Therapy Resistant OCD
Phase 3 · 8 location(s) · Amsterdam UMC, location VUmc · NCT05331937
Brain-Oscillation Synchronized Stimulation of the DMPFC
NA · 1 location(s) · Centre for Addiction and Mental Health · NCT06942559
DBS for Obsessive-Compulsive Disorder
NA · 1 location(s) · Northwell Health · NCT02773082
RNS for Treatment-resistant Obsessive-compulsive Disorder
NA · 1 location(s) · Xuanwu Hospital, Beijing · NCT06782867
Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD
Phase 2 · 1 location(s) · Beersheva Mental Health Center · NCT04882839
University of Iowa Interventional Psychiatry Service Patient Registry
Phase N/A · 1 location(s) · Mark Niciu · NCT04480918
Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD)
Phase 2 · 1 location(s) · Clinical Academic Center (2CA-Braga) · NCT06611592
Cerebral and Cognitive Markers of Treatment Resistance in Obsessive Compulsive Disorder
Phase N/A · 1 location(s) · Centre Hospitalier Henri Laborit · NCT05843604
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.